Assessment of KRAS status is mandatory in patients with metastatic colorectal cancer (mCRC)
before applying targeted therapy. We describe here a blinded prospective study to …

Background Circulating DNA (ctDNA) is acknowledged as a potential diagnostic tool for
various cancers including colorectal cancer, especially when considering the detection of …

Clinical proteomics has yielded some early positive results—the identification of potential
disease biomarkers—indicating the promise for this analytical approach to improve the current …

Although circulating DNA (ctDNA) could be an attractive tool for early cancer detection,
diagnosis, prognosis, monitoring or prediction of response to therapies, knowledge on its origin, …

Our data might suggest a very high variation in the proportion of malignant cells in colorectal
tumors and/or low tumor cell clonogenicity. However, the direct relationship between these …

Whole-cell biosensors have several advantages for the detection of biological substances
and have proven to be useful analytical tools. However, several hurdles have limited whole-…

Purpose: The identification of a molecular signature predicting the relapse of tamoxifen-treated
primary breast cancers should help the therapeutic management of estrogen receptor–…

DNA microarray technology enables investigators to measure the expression of several
1000 mRNA species simultaneously in a biological specimen. However, the reliability of the …

Purpose In patients with advanced colorectal cancer, FOLFIRI is considered as one of the
reference first-line treatments. However, only about half of treated patients respond to this bi-…

Background Colorectal cancer (CRC) is one of the most common causes of cancer death
throughout the world. In this work our aim was to study the role of the phosphoserine …